Whether left ventricular noncompaction (LVNC) is a distinct cardiomyopathy or a morphologic trait shared by different cardiomyopathies remains controversial. Current guidelines from professional organizations recommend different strategies for diagnosing and treating patients with LVNC. This state-of-the-art review discusses new insights into the basic mechanisms leading to LVNC, its clinical manifestations, treatment modalities, anatomy and pathology, embryology, genetics, epidemiology, and imaging. Three markers currently define LVNC: prominent left ventricular trabeculae, deep intertrabecular recesses, and a thin compacted layer. Although new genetic data from mice and humans supports LVNC as a distinct cardiomyopathy, evidence for LVNC as a shared morphological trait is not ruled out. Criteria supporting LVNC as a shared morphological trait may depend on consensus guidelines from the multiple professional organizations.
This state-of-the-art review includes data from embryology, genetic studies, epidemiology, and imaging studies (as outlined in a recent editorial on the evolution of translational medicine [4] ), and provides an up-to-date view of current findings on the controversial topic of LVNC.
this review on the basis of the most up-to-date criteria.
The LVNC trait may be familial (inherited) or nonfamilial (sporadic). Nonfamilial forms are diagnosed when LVNC is proven absent in relatives (5) .
Sporadic LVNC can be acquired, as in highly-trained athletes (6) , sickle cell anemia patients (7) , and pregnancy (8) . In the pregnancy study by Gati et al. (8) , 73% of affected women demonstrated complete resolution of the trabeculation during post-partum follow-up (8) . In some cases, the trabeculation phenotype may occur in response to a mechanical load, and may disappear as the mechanical load dissipates. It is not known if there is a genetic underpinning to the disease in these cases (6) (7) (8) .
Cases in children suggest that 75% have electrocardiogram abnormalities, and most have depressed systolic function (9) . Some children have transient recovery followed by later deterioration, suggesting that these cases in children are genetic in nature.
The genetic bases of familial LVNC are still a matter of research. Most familial cases identified to date are associated with mutations in the same genes that cause other types of cardiomyopathies (10, 11) .
Whether these disease genes cause the cardiomyopathy or the LVNC phenotype remains to be clarified (12) . A limitation of many (but not all) of these genetic studies is that most only screened genes associated with other cardiomyopathies, such as sarcomeric genes, which are also associated with hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and dilated cardiomyopathy (DCM).
Although there is no current gold standard for LVNC diagnosis, cardiac imaging is the best tool currently available. Pathoanatomic investigation in autopsy hearts or in hearts excised at transplantation provides data for pathoimaging correlations and assessment of imaging-based diagnoses (13) . The most commonly used imaging modalities include echocardiography and cardiac magnetic resonance (CMR).
Echocardiography provides the basic tool for diagnosis (14) , whereas CMR adds anatomic details and functional information on kinesis of the noncompacted versus compacted segments and fibrosis (15) . The limitations of imaging will be discussed.
Clinical management is based on the functional phenotype and related complications. The management of atrial and ventricular arrhythmias, device implantation, resynchronization, ablation procedures, and even LV surgical remodeling has been a matter of specific attention, raising the question of whether LVNC deserves specific medical strategies (4,16).
EMBRYOGENIC AND NONEMBRYOGENIC HYPOTHESES
There can be multiple etiologic bases of LVNC: it may occur as an isolated trait or disease (I-LVNC); in association with genetic diseases and congenital defects; be sporadic and acquired in physiological (6) or pathologic conditions (7); or be permanent or transient (8) . Therefore, LVNC can originate during embryonic development or be acquired later in life. 
ANATOMY AND PATHOLOGY
In hearts excised at transplantation or at autopsy, LVNC diagnosis is on the basis of the prominent appearance of LV trabeculae and the ratio between the compacted and noncompacted LV wall (13) .
Sectioning of formalin-fixed hearts provides the best way of measuring compacted and noncompacted layers (34) . Prominent trabeculae and thin, compacted myocardial layers can be described either In patients with LVNC associated with other congenital heart diseases, the deep intertrabecular recesses communicate with both the LV cavity and the coronary circulation (33) . LVNC was first described by Bellet and Gouley (38) Other LVNC-associated genes in Table 1 Abbreviations as in Figure 3 . (39) . Importantly, to avoid misdiagnosis, compact papillary muscle should be distinguished from prominent trabeculations, which is quite easy to do with the 3-dimensional dataset acquired during CMR.
Fractal analysis was also used to quantify LV trabeculae (15) . In a recent study of 30 patients, the combination of end-diastolic measurements at basal, mid, and apical segments was found to be the best selector of LVNC cases from the normal population 
